These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Synergistic effect of SCF and TNF-alpha on the up-regulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells. Tsang CM; Wong CK; Ip WK; Lam CW J Leukoc Biol; 2005 Jul; 78(1):239-47. PubMed ID: 15800027 [TBL] [Abstract][Full Text] [Related]
27. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells. Cohen M; Meisser A; Haenggeli L; Bischof P Mol Hum Reprod; 2006 Apr; 12(4):225-32. PubMed ID: 16520344 [TBL] [Abstract][Full Text] [Related]
28. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha. Furusu A; Nakayama K; Xu Q; Konta T; Kitamura M J Cell Physiol; 2007 Mar; 210(3):703-10. PubMed ID: 17133355 [TBL] [Abstract][Full Text] [Related]
29. Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation. Bai YP; Liu YH; Chen J; Song T; You Y; Tang ZY; Li YJ; Zhang GG Biochem Biophys Res Commun; 2007 Aug; 360(1):20-6. PubMed ID: 17583675 [TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells. Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852 [TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB. Wong CK; Tsang CM; Ip WK; Lam CW Allergy; 2006 Mar; 61(3):289-97. PubMed ID: 16436136 [TBL] [Abstract][Full Text] [Related]
32. Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Zhang C; Kawauchi J; Adachi MT; Hashimoto Y; Oshiro S; Aso T; Kitajima S Biochem Biophys Res Commun; 2001 Dec; 289(3):718-24. PubMed ID: 11726207 [TBL] [Abstract][Full Text] [Related]
33. Dual role of TMS1/ASC in death receptor signaling. Parsons MJ; Vertino PM Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133 [TBL] [Abstract][Full Text] [Related]
35. Effects of antisense IRAK-2 oligonucleotides on PGI2 release induced by IL-1 and TNF. Li YL; Guo FK; Wu SG Acta Pharmacol Sin; 2000 Jul; 21(7):646-8. PubMed ID: 11360675 [TBL] [Abstract][Full Text] [Related]
36. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling. Sessler T; Healy S; Samali A; Szegezdi E Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861 [TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. Yan W; Tiruppathi C; Qiao R; Lum H; Malik AB J Cell Physiol; 1996 Mar; 166(3):561-7. PubMed ID: 8600159 [TBL] [Abstract][Full Text] [Related]
38. TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. Jones SJ; Ledgerwood EC; Prins JB; Galbraith J; Johnson DR; Pober JS; Bradley JR J Immunol; 1999 Jan; 162(2):1042-8. PubMed ID: 9916731 [TBL] [Abstract][Full Text] [Related]
39. [Effects of TNF-alpha or mmLDL on PAI-1 expression in human umbilical vein endothelial cells]. Li XD; Zu SY; Zhu GJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):156-9. PubMed ID: 12905793 [TBL] [Abstract][Full Text] [Related]
40. Agonist antibody activates death receptor 6 downstream signaling involving TRADD recruitment. Hu R; Du Q; Yin X; Li J; Wang T; Zhang L FEBS Lett; 2014 Jan; 588(3):401-7. PubMed ID: 24374337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]